查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球冻干注射剂市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测
市场调查报告书
商品编码
1342746

全球冻干注射剂市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

Global Lyophilized Injectable Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 283 Pages | 商品交期: 最快1-2个工作天内

价格

全球冻干注射剂市场需求预计将从 2022 年的 69.3 亿美元增至 2030 年的近 137.3 亿美元，2023-2030 年研究期间复合年增长率为 8.92%。

冻干注射剂是冻干药物，在运输过程中保持稳定。冻干注射剂是使用冻干工艺生产的，该工艺涉及在真空下冷冻和蒸发溶液，以从溶剂中分离出固体物质。冻干注射剂被认为是口服具体剂型的最有效替代品。卧床不起的人从冻干注射剂中受益匪浅。冻干注射剂还可以为患有各种疾病的患者提供最大程度的吸收和稳定性，因为它们的保质期比其他剂量更长。

市场动态

推动冻干注射剂市场增长的重要因素是对合同研究製造服务的需求增加和药品审批的增加。冻干注射药物的不断进步的技术进步可能会推动冻干注射药物的增长。对冻干药物的监管批准增加可能会刺激对冻干注射药物的需求。冻干药品召回数量和包装类型的增加预计将限制冻干注射剂市场。与註射产品冻干瓶生产相关的因素可能对这些药物构成挑战，限制市场增长。

该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球冻干注射剂市场的每个细分市场进行了包容性评估。冻干注射剂行业的增长和趋势为本研究提供了整体方法。

市场细分

冻干注射剂市场报告的这一部分提供了国家和区域层面细分市场的详细数据，从而帮助战略家确定相应产品或服务的目标人群以及即将到来的机会。

按包装

  • 一次性小瓶
  • 护理点重构
  • 专业包装

送货方式

  • 预装稀释剂注射器
  • 专有的重构设备
  • 单步设备
  • 多步设备

按指示

  • 自身免疫性疾病
  • 传染性疾病
  • 代谢状况
  • 其他的

按最终用户

  • 医院
  • 门诊手术中心
  • 专科诊所
  • 其他的
  • 区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲冻干注射剂市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。冻干注射剂市场的主要参与者包括 B. Braun Melsungen AG、Baxter International Inc.、BD、Schott AG、Aristopharma Ltd.、Vetter Pharma、Jubilant HollisterStier LLC。本节包含竞争格局的整体视图，包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市场亮点
  • 全球市场概况

第 3 章：冻干注射剂 - 行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 行业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按包装进行的市场吸引力分析
    • 按交付进行的市场吸引力分析
    • 按指标进行的市场吸引力分析
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原料厂商清单
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直效行销
    • 间接营销
    • 营销渠道发展趋势

第 5 章：COVID-19 爆发的影响分析

第 6 章：全球冻干注射剂市场分析：按包装分类

  • 按包装概述
  • 历史和预测数据
  • 按包装分析
  • 一次性小瓶
  • 现场护理重构
  • 专业包装

第 7 章：全球冻干注射剂市场分析：按交付方式

  • 按交付概览
  • 历史和预测数据
  • 按交付分析
  • 预装稀释剂注射器
  • 专有的重构设备
  • 单步设备
  • 多步装置

第 8 章：全球冻干注射剂市场分析：按适应症分类

  • 按适应症概述
  • 历史和预测数据
  • 按指标分析
  • 自身免疫性疾病
  • 传染性疾病
  • 代谢状况
  • 其他的

第 9 章：全球冻干注射剂市场分析：按最终用户分类

  • 最终用户概述
  • 历史和预测数据
  • 最终用户分析
  • 医院
  • 门诊手术中心
  • 专科诊所
  • 其他的

第 10 章：全球冻干注射剂市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美按细分市场销售分析
    • 北美按国家/地区销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家/地区销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家/地区销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 11 章：冻干注射剂公司的竞争格局

  • 冻干注射剂市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 12 章：公司简介

  • 顶级公司股票分析
  • 市场集中度
  • B. Braun Melsungen AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Baxter International Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BD
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Schott AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Aristopharma Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Vetter Pharma
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Jubilant HollisterStier LLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

Product Code: VMR11219936

The global demand for Lyophilized Injectable Market is presumed to reach the market size of nearly USD 13.73 BN by 2030 from USD 6.93 BN in 2022 with a CAGR of 8.92% under the study period 2023 - 2030.

Lyophilized injectables are freeze-dried medications that remain stable during transportation. Lyophilized injectables are created using the lyophilization process, which involves freezing and evaporating a solution under a vacuum to isolate a solid substance from a solvent. Lyophilized injectables are regarded as the most effective alternative to oral concrete dose forms. Bedridden individuals have greatly benefited from lyophilized injectables. Lyophilized injectables also provide maximum absorption and stability in patients suffering from various disorders since they have a longer shelf life than other doses.

MARKET DYNAMICS:

The vital factors driving the growth of the lyophilized injectables market are increased demand for contract research manufacturing services and rising pharmaceutical approvals. The increasing technological improvements in lyophilized injectable medications will likely fuel the growth of lyophilized injectable drugs. The increased regulatory approvals for lyophilized pharmaceuticals will likely stimulate demand for lyophilized injectable medications. The increase in the number of lyophilized medication product recalls and packaging types are projected to restrict the lyophilized injectable market. Factors related to the production of lyophilized vials for injectable products likely pose a challenge for these medications limiting the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of lyophilized injectable. The growth and trends of lyophilized injectable industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the lyophilized injectable market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Packaging

  • Single-Use Vials
  • Point-Of-Care Reconstitution
  • Specialty Packaging

By Delivery

  • Prefilled Diluent Syringes
  • Proprietary Reconstitution Devices
  • Single-Step Devices
  • Multi-Step Devices

By Indication

  • Autoimmune Diseases
  • Infectious Diseases
  • Metabolic Conditions
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Lyophilized Injectable market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the lyophilized injectable market include B. Braun Melsungen AG, Baxter International Inc., BD, Schott AG, Aristopharma Ltd., Vetter Pharma, Jubilant HollisterStier LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . LYOPHILIZED INJECTABLE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Packaging
    • 3.7.2 Market Attractiveness Analysis By Delivery
    • 3.7.3 Market Attractiveness Analysis By Indication
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY PACKAGING

  • 6.1 Overview by Packaging
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Packaging
  • 6.4 Single-use Vials Historic and Forecast Sales by Regions
  • 6.5 Point-of-care Reconstitution Historic and Forecast Sales by Regions
  • 6.6 Specialty Packaging Historic and Forecast Sales by Regions

7 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY DELIVERY

  • 7.1 Overview by Delivery
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Delivery
  • 7.4 Prefilled Diluent Syringes Historic and Forecast Sales by Regions
  • 7.5 Proprietary Reconstitution Devices Historic and Forecast Sales by Regions
  • 7.6 Single-step Devices Historic and Forecast Sales by Regions
  • 7.7 Multi-step Devices Historic and Forecast Sales by Regions

8 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY INDICATION

  • 8.1 Overview by Indication
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Indication
  • 8.4 Autoimmune Diseases Historic and Forecast Sales by Regions
  • 8.5 Infectious Diseases Historic and Forecast Sales by Regions
  • 8.6 Metabolic Conditions Historic and Forecast Sales by Regions
  • 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY END USER

  • 9.1 Overview by End User
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End User
  • 9.4 Hospitals Historic and Forecast Sales by Regions
  • 9.5 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
  • 9.6 Specialty Clinics Historic and Forecast Sales by Regions
  • 9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE LYOPHILIZED INJECTABLE COMPANIES

  • 11.1. Lyophilized Injectable Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF LYOPHILIZED INJECTABLE INDUSTRY

  • 12.1. Top Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. B. Braun Melsungen AG
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Baxter International Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. BD
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Schott AG
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Aristopharma Ltd.
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Vetter Pharma
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Jubilant HollisterStier LLC
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Packaging (USD MN)
  • Single-use Vials Market Sales by Geography (USD MN)
  • Point-of-care Reconstitution Market Sales by Geography (USD MN)
  • Specialty Packaging Market Sales by Geography (USD MN)
  • Analysis Market by Delivery (USD MN)
  • Prefilled Diluent Syringes Market Sales by Geography (USD MN)
  • Proprietary Reconstitution Devices Market Sales by Geography (USD MN)
  • Single-step Devices Market Sales by Geography (USD MN)
  • Multi-step Devices Market Sales by Geography (USD MN)
  • Analysis by Indication (USD MN)
  • Autoimmune Diseases Market Sales by Geography (USD MN)
  • Infectious Diseases Market Sales by Geography (USD MN)
  • Metabolic Conditions Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales by Geography (USD MN)
  • Specialty Clinics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Lyophilized Injectable Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Lyophilized Injectable Report
  • Market Research Process
  • Market Research Methodology
  • Global Lyophilized Injectable Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Packaging
  • Market Attractiveness Analysis by Delivery
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Packaging (USD MN)
  • Single-use Vials Market Sales by Geography (USD MN)
  • Point-of-care Reconstitution Market Sales by Geography (USD MN)
  • Specialty Packaging Market Sales by Geography (USD MN)
  • Global Market Analysis by Delivery (USD MN)
  • Prefilled Diluent Syringes Market Sales by Geography (USD MN)
  • Proprietary Reconstitution Devices Market Sales by Geography (USD MN)
  • Single-step Devices Market Sales by Geography (USD MN)
  • Multi-step Devices Market Sales by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Autoimmune Diseases Market Sales by Geography (USD MN)
  • Infectious Diseases Market Sales by Geography (USD MN)
  • Metabolic Conditions Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales by Geography (USD MN)
  • Specialty Clinics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.